InvestorsHub Logo

C2Guy

11/09/23 3:30 AM

#158035 RE: MJAM2020 #158027

Read Page 23 of the 2023 Annual Report.

"Our common stock is subject to substantial dilution by exercises of warrants and conversions or exercises of other securities into common stock...As of March 30, 2023, the total potentially dilutive shares of common stock, including outstanding common stock, was 1.0 trillion."

December 31, 2022
Shares of common stock outstanding...................29,084,322,257
Dilutive potential shares:
Common stock warrants......................................511,333,351,090
Convertible preferred stock..................................452,995,411,111
Convertible debentures.........................................28,777,833,333
Stock options..............................................................................26
Total potentially dilutive shares of common
stock, including outstanding common stock.....1,022,190,917,817

https://ir.rennovahealth.com/all-sec-filings?form_type=10-K&document-15097-0001493152-17-010881#document-15864-0001493152-23-012549